Delta opioid receptors stimulation with [d-Ala2, d-Leu5] enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia

Neuroscience Letters

Volumn 414, Issue 3, 2007, Pages 242-246

  Iwata, Masato ^a   Inoue, Satoki ^a   Kawaguchi, Masahiko ^a   Kurita, Naoko ^a   Horiuchi, Toshinori ^a   Nakamura, Mitsutoshi ^a   Konishi, Noboru ^a   Furuya, Hitoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

DADLE; Delta opioid; Forebrain ischemia; Hippocampus; Neuroprotection

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ISOFLURANE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; HISTOLOGY; HYPOTENSION; HYPOTHESIS; MALE; MOTOR ACTIVITY; NERVE CELL NECROSIS; NEUROLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; UPPER RESPIRATORY TRACT OBSTRUCTION;

ANALGESICS, OPIOID; ANIMALS; BRAIN ISCHEMIA; CELL SURVIVAL; CEREBRAL INFARCTION; DENTATE GYRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, LEUCINE-2-ALANINE; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; TREATMENT FAILURE;

EID: 33847240432     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.12.021     Document Type: Article

References (22)

1. Acosta C.G., and Lopez H.S. Delta opioid receptor modulation of several voltage-dependent Ca(2+) currents in rat sensory neurons. J. Neurosci. 19 (1999) 8337-8348
2. Baker A.K., and Meert T.F. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. J. Pharmacol. Exp. Ther. 302 (2002) 1253-1264
3. 2O. Anesthesiology 69 (1988) 192-198
4. Borlongan C.V., Su T.P., and Wang Y. Treatment of delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport 11 (2000) 923-926
5. Chen W., Yang J.Z., Andersen R., Nielsen L.H., and Borchardt R.T. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model. J. Pharmacol. Exp. Ther. 303 (2002) 849-857
6. Cohen M.V., Baines C.P., and Downey J.M. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu. Rev. Physiol. 62 (2000) 79-109
7. Fryer R.M., Hsu A.K., Eells J.T., Nagase H., and Gross G.J. Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ. Res. 84 (1999) 846-851
8. Ginsberg M.D., and Busto R. Rodent models of cerebral ischemia. Stroke 20 (1989) 1627-1642
9. Hayashi T., Tsao L.I., and Su T.P. Antiapoptotic and cytotoxic properties of delta opioid peptide [d-Ala2, d-Leu5]enkephalin in PC12 cells. Synapse 43 (2002) 86-94
10. Horiuchi T., Kawaguchi M., Sakamoto T., Kurita N., Inoue S., Nakamura M., Konishi N., and Furuya H. The effects of the delta-opioid agonist SNC80 on hind-limb motor function and neuronal injury after spinal cord ischemia in rats. Anesth. Analg. 99 (2004) 235-240
11. Kastin A.J., Nissen C., Schally A.V., and Coy D.H. Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog. Brain Res. Bull. 1 (1976) 583-589
12. Miki T., Cohen M.V., and Downey J.M. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol. Cell. Biochem. 186 (1998) 3-12
13. Miura Y., Grocott H.P., Bart R.D., Pearlstein R.D., Dexter F., and Warner D.S. Differential effects of anesthetic agents on outcome from near-complete but not incomplete global ischemia in the rat. Anesthesiology 89 (1998) 391-400
14. Palkovis M., and Brownstein M.J. Maps and Guide to Microdissection of the Rat Brain (1988), Elsevier, New York, NY
15. Sano T., Patel P.M., Drummond J.C., and Cole D.J. A comparison of the cerebral protective effects of etomidate, thiopental, and isoflurane in a model of forebrain ischemia in the rat. Anesth. Analg. 76 (1993) 990-997
16. Schultz J.e.-J., Hsu A.K., Nagase H., and Gross G.J. TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am. J. Physiol. 274 (1998) H909-H914
17. Schultz J.E., Hsu A.K., and Gross G.J. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation 97 (1998) 1282-1289
18. Su T.P. Delta opioid peptide [d-Ala2, d-Leu5]enkephalin promotes cell survival. J. Biomed. Sci. 7 (2000) 195-199
19. Tsao L.I., Ladenheim B., Andrews A.M., Chiueh C.C., Cadet J.L., and Su T.P. Delta opioid peptide [d-Ala2, d-Leu5]enkephalin blocks the long-term loss of dopamine transporter induced by multiple administration of methamphetamine: involvement of opioid receptors and reactive oxygen species. J. Pharmacol. Exp. Ther. 287 (1998) 322-331
20. Vereczki V., Martin E., Rosenthal R.E., Hof P.R., Hoffman G.E., and Fiskum G. Normoxic resuscitation after cardiac arrest protects against hippocampal oxidative stress, metabolic dysfunction, and neuronal death. J. Cereb. Blood Flow Metab. 26 (2006) 821-835
21. Zhang J.H., Haddad G.G., and Xia Y. Delta-, but not mu- and kappa-opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 885 (2000) 143-153
22. Zhang J., Gibney G.T., Zhao P., and Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am. J. Physiol. Cell Physiol. 282 (2002) C1225-C1234